Desmopressin acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for desmopressin acetate and what is the scope of freedom to operate?
Desmopressin acetate
is the generic ingredient in eleven branded drugs marketed by Ferring Pharms Inc, Am Regent, Bedford, Dr Reddys, Gland, Gland Pharma Ltd, Hospira, Meitheal, Sagent Pharms Inc, Sun Pharm Inds Ltd, UBI, Ferring, Sun Pharm Inds, Bausch, Apotex, Sun Pharm, Zydus Pharms, Acerus Pharms, Abhai Llc, Actavis Labs Fl Inc, Apotex Inc, Glenmark Pharms Ltd, Heritage Pharma, Impax Labs Inc, Natco Pharma Usa, and Novast Labs, and is included in thirty-five NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Desmopressin acetate has two hundred and eight patent family members in thirty-six countries.
There are thirteen drug master file entries for desmopressin acetate. Twenty-eight suppliers are listed for this compound.
Summary for desmopressin acetate
International Patents: | 208 |
US Patents: | 7 |
Tradenames: | 11 |
Applicants: | 26 |
NDAs: | 35 |
Drug Master File Entries: | 13 |
Finished Product Suppliers / Packagers: | 28 |
Raw Ingredient (Bulk) Api Vendors: | 133 |
Clinical Trials: | 10 |
Patent Applications: | 1,242 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for desmopressin acetate |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for desmopressin acetate |
What excipients (inactive ingredients) are in desmopressin acetate? | desmopressin acetate excipients list |
DailyMed Link: | desmopressin acetate at DailyMed |
Recent Clinical Trials for desmopressin acetate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cairo University | N/A |
Indiana Hemophilia &Thrombosis Center, Inc. | Phase 4 |
Genentech, Inc. | Phase 4 |
Pharmacology for desmopressin acetate
Drug Class | Factor VIII Activator Vasopressin Analog |
Physiological Effect | Increased Coagulation Factor VIII Activity Increased Coagulation Factor VIII Concentration |
US Patents and Regulatory Information for desmopressin acetate
Expired US Patents for desmopressin acetate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-001 | Jun 21, 2018 | ⤷ Try a Trial | ⤷ Try a Trial |
Ferring | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 021795-002 | May 8, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Acerus Pharms | NOCTIVA | desmopressin acetate | SPRAY, METERED;NASAL | 201656-002 | Mar 3, 2017 | ⤷ Try a Trial | ⤷ Try a Trial |
Ferring Pharms Inc | DDAVP | desmopressin acetate | SOLUTION;NASAL | 017922-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Ferring Pharms Inc | DDAVP | desmopressin acetate | SOLUTION;NASAL | 017922-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Ferring Pharms Inc | DDAVP | desmopressin acetate | INJECTABLE;INJECTION | 018938-001 | Mar 30, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for desmopressin acetate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 03094885 | ⤷ Try a Trial | |
European Patent Office | 2442821 | ADMINISTRATION SÛRE DE DESMOPRESSINE (SAFE DESMOPRESSIN ADMINISTRATION) | ⤷ Try a Trial |
South Korea | 101792696 | ⤷ Try a Trial | |
Croatia | P20191854 | ⤷ Try a Trial | |
Denmark | 3278809 | ⤷ Try a Trial | |
European Patent Office | 3006036 | DESMOPRESSINE POUR LA RÉDUCTION DE VIDES NOCTURNES (DESMOPRESSIN FOR REDUCING NOCTURNAL VOIDS) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for desmopressin acetate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3225249 | CA 2019 00023 | Denmark | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504 |
3225249 | 300983 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSIN, DESGEWENST IN DE VORM VAN EEN ACETAAT ZOUT; REGISTRATION NO/DATE: BE497271 & BE497280 20160513 |
3225249 | 2019C/520 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513 |
2712622 | C02712622/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66379 16.03.2018 |
2712622 | 122017000006 | Germany | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504 |
2712622 | LUC00015 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.